NICE recommends new treatment option for multiple sclerosis
In final guidance, the National Institute for Health and Care Excellence (NICE) has recommended the use of Biogen Idec’s multiple sclerosis drug, dimethyl fumarate (also called Tecfidera). The NHS now
Read More